n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, August 1st, 2017

The QualityStocks
Daily Stock List

graphic
graphic

The Chron Organization, Inc. (CHRO)

Promotion Stock Secrets reported recently on The Chron Organization, Inc. (CHRO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

The Chron Organization, Inc.’s purpose is to develop a portfolio of highly successful and innovative wholly-owned businesses through providing incubation, advisory, and capital services to the same. Mr. Byron Young and Mr. Alex Rodriguez founded and envisioned the Company. An incubator, The Chron Organization specializes in start-ups.

The Company takes advantage of its expertise, network, and resources in taking creative companies from founding through the different phases of the business lifecycle, including exit. The Chron Organization has its corporate headquarters in Dallas, Texas. The Company’s interests include smart home services, Internet of Things (IOT) platforms, deregulated energy and energy efficiency offerings.

At the end of May 2017, The Chron Organization announced that it entered into a strategic marketing agreement with nationally prominent direct selling organization, Viridian International Management for medium to large commercial services. Because of the agreement, Chron and Viridian officially launched a joint commercial energy program on June 5, 2017, targeting mid to large size commercial, industrial, and municipal end-use customers of electricity and/or natural gas.

The agreement combines Viridian's innovative marketing approach, with newly acquired Chron subsidiary, NAUP Brokerage LLC's (NAUP) experience, technology, and knowledge of the energy markets, to create a sales approach and infrastructure ready for full operation in all United States deregulated energy markets.

Recently, Zen Technologies, Inc., a wholly-owned subsidiary of The Chron Organization, announced that it officially began installations of its first Zero-Cost customer. This project covers installing the Company's smart controls, energy conservation technologies, retrofits, and efficiency upgrades at the business properties of the first of seven commercial customers. The first seven Zero-Cost Program deals range in contract value from $70,000 up to $875,000 per deal.

Zen Technologies is a home services enterprise. Its mission is to make the "Smart Home" a reality for the millions of homeowners and apartment homes across the U.S. Zen Technologies provides homeowners with the latest in security, monitoring, and automation controls.

Last week, The Chron Organization announced its application for quotation of its Class A Common Stock on the OTC Markets Group’s OTCQB tier was approved by the OTC after meeting all the applicable listing requirements.

The Chron Organization, Inc. (CHRO), closed Tuesday's trading session at $0.029, up 5.26%, on 374,527 volume with 33 trades. The average volume for the last 60 days is 503,668 and the stock's 52-week low/high is $0.016/$0.048.

Skyharbour Resources Ltd. (SYHBF)

Vantage Wire reported previously on Skyharbour Resources Ltd. (SYHBF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Skyharbour Resources Ltd. is a uranium and thorium exploration Company headquartered in Vancouver, British Columbia. It has projects in the prolific Athabasca Basin of the Province of Saskatchewan. Skyharbour Resources has five drill-ready projects (totaling greater than 250,000 hectares throughout the Athabasca Basin). The Company’s objective is to maximize shareholder value by way of new mineral discoveries, committed long-term partnerships, and the advancement of exploration projects in geopolitically favourable jurisdictions.

The Athabasca Basin provides exploration companies a unique opportunity. This Basin is host to the highest-grade uranium deposits globally, averaging 2 percent U3O8 with some deposits averaging more than 15 percent U3O8. Skyharbour Resources’ flagship project (earning in 100 percent) is the Moore Uranium Project.

Skyharbour Resources secured an option (in June of 2016) to purchase the 35,705-hectare Moore Uranium Project from Denison Mines (NYSE: DNN), a large strategic shareholder of Skyharbour. In early 2017, the Company carried out its initial drill program at the Moore Uranium Project. It reported 20.8 percent U3O8 over 1.5 meters within 6.0 percent U3O8 over 5.9 meters in hole ML-199. Skyharbour is planning additional drill programs at the project for this year and next year.

The Company’s other projects include Falcon Point; Preston; Mann Lake; South Bay; and Yurchison Lake. Falcon Point (100 percent interest) is a large land position (79,000 hectares) on the east side of the Athabasca Basin. Preston (50 percent with strategic partners AREVA and Azincourt earning in 70 percent) is a large land position totaling 121,148 hectares. Moreover, the Company has 100 percent interest in Mann Lake (strategically positioned adjacent to the Mann Lake Joint Venture operated by Cameco, where high grade uranium mineralization was recently discovered) and Yurchison Lake.

Recently, Skyharbour Resources announced the results from its first phase, winter 2017 diamond drilling program at its Moore Uranium Project. Numerous drill holes intersected high grade uranium mineralization at the 4-kilometer-long Maverick structural corridor. High grade results include 9.12 percent U3O8 over 1.4 meters within an interval returning 4.17 percent U3O8 over 4.5 meters in hole ML-202; 5.29 percent U3O8 over 2.5 meters within an interval returning 2.99 percent U3O8 over 5.0 meters in hole ML-200; 2.25 percent U3O8 over 3.0 meters in hole ML-208, and earlier reported 20.8 percent U3O8 over 1.5 meters within an interval returning 6.0 percent U3O8 over 5.9 meters in hole ML-199.

At the Moore Uranium Project, Skyharbour Resources is planning a 2,500-meter diamond drill program starting this month to follow up on the success of the recently completed winter 2017 drill program with planned drill targets situated on the Maverick Corridor and other regional targets planned for drill testing. Furthermore, Skyharbour is carrying out a complete data compilation program at Moore to aggregate all the historical and continuing exploration results. The Company plans to use new and inventive techniques to analyze the data to enhance the discovery potential and resource delineation at the project moving ahead.

Skyharbour Resources Ltd. (SYHBF), closed Tuesday's trading session at $0.348, up 0.29%, on 5,800 volume with 5 trades. The average volume for the last 60 days is 30,861 and the stock's 52-week low/high is $0.1828/$0.5384.

Ener-Core, Inc. (ENCR)

StockOodles, Stock News Now, Greenbackers, Lions of Wall Street, PennyStocks24, TheMicrocapNews, StreetAuthority Financial, ProfitableTrading, StockBlogs, Dividend Opportunities, Investors Alley, Trade of the Week, Pumps and Dumps, Uncommon Wisdom, Investopedia, Zacks, Insider Wealth Alert, Wyatt Investment Research, Market Authority, SuperNova Elite, and Top Stock Picks reported previously on Ener-Core, Inc. (ENCR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ener-Core, Inc. is a developer and licensor of unique gas conversion technologies for worldwide commercial and industrial facilities. The Company owns and licenses its proprietary Power Oxidation technology. This technology has been commercially deployed and generates base load, clean power from polluting waste gases, including methane. Ener-Core has its headquarters in Irvine, California.

The design of Ener-Core’s patented Power Oxidizer is to turn one of the most potent pollution sources into a profitable, "always on" source of clean energy. The Company’s technology provides an alternative to the flaring (burning) of gaseous pollution. It does so while generating operating efficiencies and lessening the costs of compliance with environmental regulations.

Ener-Core offers the 250 kW Ener-Core EC250. It also offers the larger, 2 MW Ener-Core Powerstation KG2-3GEF/PO. The Ener-Core Power Oxidizer 250 KW (EC250) Powerstation is the only clean power generation solution that runs directly on low pressure, low quality gases, which normally cannot be used or even flared. The Dresser-Rand Power Oxidizer 2 MW (KG2-3GEF/PO) Powerstation’s gas turbine with Ener-Core Power Oxidizer technology is the only clean power generation that runs directly on low-pressure, low-quality gases, which otherwise could not be utilized.

The patented Ener-Core Power Oxidizer and associated oxidation process (when teamed with gas turbines) enables the conversion of these gases into useful heat and power with the lowest known associated emissions. In addition, the Power Oxidizer can undergo customization for integration with larger existing power generation systems to provide consummate pollution control and attain zero emissions.

In April of this year, Ener-Core announced that it and the Dresser-Rand business, part of Siemens Power and Gas Division, amended their June 2016 Commercial and Manufacturing License Agreement (CMLA) to advance a partial payment of $1.2 million in license fees associated with the commercial sales of Power Oxidation (PO) systems within the 2 MW power capacity.

The Dresser-Rand business also has the option to structure a new commercial offering with Ener-Core, which will expand upon the power capacity of the Power Oxidation systems, from the presently licensed 1-4 MW range to potentially integrate the greater power capacity versions with the larger range of Siemens gas turbines.

Recently, Ener-Core appointed Mr. James Reiman to its Board of Directors. In conjunction with the appointment, Mr. Jeffrey Horn has transitioned from Director to a member of Ener-Core's Senior Advisory Board. Mr. Reiman brings over three decades of management, financial, and legal experience with domestic and global public and private companies. He was the Founder, Chief Executive Officer, and Managing Member of Aerofficient LLC, which designed and manufactured aerodynamic fairings for heavy-duty truck trailers.

Ener-Core, Inc. (ENCR), closed Tuesday's trading session at $1.51, up 0.67%, on 221 volume with 3 trades. The average volume for the last 60 days is 2,230 and the stock's 52-week low/high is $0.92/$3.60.

PetroShare Corp. (PRHR)

DreamTeamNetwork and SmallCapVoice reported previously on PetroShare Corp. (PRHR), and we report on the Company today, here at the QualityStocks Daily Newsletter.

PetroShare Corp. is a domestic oil and natural gas exploration and development company. It targets capital deployment opportunities in established unconventional resource plays. The Company established to investigate, acquire, and develop oil and gas properties in the Rocky Mountain and mid-continent regions of the U.S. PetroShare’s current emphasis is in the Niobrara/Codell formations and adjacent oil and gas producing zones in the Rocky Mountain area. Specific targets are in the Wattenberg field within the DJ Basin of northeast Colorado. PetroShare is based in Centennial, Colorado.  

The Company is expanding its group of properties via organic drilling and development, in addition to strategic acquisitions and joint ventures (JVs). Its properties include Todd Creek Farms (Southern Wattenberg Field, NE Colorado; Niobrara and Codell Oil and Gas Development). PetroShare acquired an initial acreage position of approximately 1280 gross acres (333 net acres) in the heart of the oil dominated Niobrara/Codell resource development fairway in the southern end of the Greater Wattenberg Field area of NE Colorado.

In addition, the Company’s properties include the Buck Peak Prospect (Sand Wash Basin, NW Colorado; Niobrara Oil Development). This Prospect is 7,700 gross acres (1,000 net acres) situated in Moffat County. PetroShare has drilled and completed two producing wells in this prospect. The Buck Peak Prospect targets oil and associated wet gas from the fractured Niobrara Shale formation.

This past April, PetroShare announced its proved reserves as of December 31, 2016, as prepared by Cawley, Gillespie & Associates, the Company's third-party reserve engineer, were about 6.3 million barrels of oil equivalent. The estimated pre-tax value of future cash flows from its proved reserves, discounted at 10 percent (PV-10), was roughly $43 million, using commodity prices of $42.75 per barrel of oil (Bbl) and $2.48 per MMBtu of natural gas. The volume of the proved reserves is split 70 percent for oil and natural gas liquids (NGL) and 30 percent for natural gas.

In May, PetroShare provided an operations update. In Q1, it averaged roughly 440 BOED net to its interest. This includes contributions from newly completed non-operated wells, many of which came on production late in Q1.

The ramp up in production continued in Q2 as the Company exited April 2017 at a rate of around 1,300 BOED (3 phase) net to PetroShare. Its operating development program got underway in March on its Shook pad in Adams County, Colorado.

The Shook pad development program consists of 6 Codell wells and 8 Niobrara wells targeting all three Niobrara benches. The expectation is that drilling operations on the Shook pad will end early in Q3. Completion activities are planned to start later in Q3.

PetroShare Corp. (PRHR), closed Tuesday's trading session at $1.75, up 7.69%, on 721 volume with 2 trades. The average volume for the last 60 days is 1,114 and the stock's 52-week low/high is $0.875/$2.00.

Noble Roman's, Inc. (NROM)

StockOodles, Wall Street Resources, FeedBlitz, Marketbeat, The Bowser Report, TaglichBrothers, and SmallCapVoice reported earlier on Noble Roman's, Inc. (NROM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. Its business model consists of three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. The Company franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub trade names. Noble Roman's is headquartered in Indianapolis, Indiana.  

The Company has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. In addition, it has awarded franchise and/or license agreements in Puerto Rico, the Bahamas, Italy, Canada, and the Dominican Republic.

Concerning Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the types of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.

Grocery Take-n-Bake Licensing involves licensing of individual Groceries to sell Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.

Regarding Non-Traditional Venues, these are usually located in a host facility whose principal business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit. Example kinds of locations include Convenience Stores; Walmart®/Retail Centers; Entertainment Facilities; Bowling Centers; Hospitals; and Military Bases.

Noble Roman's opened its first location in February of this year for its new-generation, stand-alone pizzeria concept called “Noble Roman's Craft Pizza & Pub”. The initial location opened in 4,000 square feet of the newly constructed Monon Marketplace on Main Street/Highway 32 across from Grand Park in Westfield, Indiana.

The Company’s Craft Pizza & Pub features two styles of hand-crafted, made-from-scratch pizzas with a selection of 40 different toppings, cheeses, and sauces. Also, beer and wine is featured, with 16 different beers on tap.

The first unit of Noble Roman's Craft Pizza & Pub continued to surpass Company Management pre-opening expectations by more than 50 percent. During its first full calendar month of operation in February 2017, net sales were greater than $150,000, with an operating margin of more than 33 percent.

Noble Roman's, Inc. (NROM), closed Tuesday's trading session at $0.45, even for the day, on 5,150 volume with 6 trades. The average volume for the last 60 days is 14,000 and the stock's 52-week low/high is $0.3562/$0.8828.

graphic

The QualityStocks
Company Corner

graphic
graphic

Lexaria Bioscience Corp. (CSE:LXX) (OTCQB:LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP). Today, Lexaria Bioscience Corp. closed trading at $0.4099, up 1.30%, on 169,484 volume with 69 trades. The stock’s average daily volume over the past 60 days is 78,576 and its 52-week low/high is $0.0913/$0.699.

Lexaria Bioscience Corp. (LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body's gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria's products and others on the market is the company's disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the "unusual" taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company's technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria's processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government's National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria's unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience's business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company's patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria's lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world's most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria's revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company's growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets. Disclaimer

Lexaria Bioscience Corp. Blog

Lexaria Bioscience Corp. News:

NetworkNewsWire Announces Publication Highlighting the Operations of Several Public Cannabis-Biotech Companies

Lexaria Bioscience Technology Discussed by CFN Media Cannabis Industry Coverage

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is “One to Watch”

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.72, up 0.98%, on 95,060 volume with 40 trades. The stock’s average daily volume over the past 60 days is 35,634 and its 52-week low/high is $0.20/$2.09.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub, Inc. Introduces Fourth Medical Software Service Line, Continuing Rapid Expansion Strategy

ORHub, Inc. Executing Aggressive Expansion Strategy with Introduction of Third Service Line

ORHub, Inc. Signs National Deployment Agreement to Roll-out Transformative Medical Software in Major U.S. Markets

InMed Pharmaceuticals, Inc. (IMLFF)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals, Inc. (IMLFF). Today, InMed Pharmaceuticals, Inc. closed trading at $0.256, off by 1.16%, on 259,920 volume with 106 trades. The stock’s average daily volume over the past 60 days is 373,664, and its 52-week low/high is $0.0501/$0.72.

InMed Pharmaceuticals, Inc. (IMLFF) is a preclinical-stage biopharmaceutical company specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. Utilizing its proprietary bioinformatics assessment tool, InMed aims to identify bioactive compounds found within the cannabis plant that have the potential to offer optimized therapeutic benefit while demonstrating limited adverse effects. This assessment tool, in combination with the company’s cannabinoid biosynthesis technology and drug development pipeline, serves as InMed’s fundamental value driver.

Bioinformatics is a proprietary, computer-based program designed to assist in the identification of novel cannabinoids using comprehensive algorithms to integrate data from numerous bioinformatics databases, as well as a database on the structure of currently approved pharmaceutical products and an extensive database on over 90 individual cannabinoid drugs found in cannabis. This extensive collection of data is derived from both public and propriety-based sources. Leveraging this tool, the company aims to create associations between approved pharmaceuticals and cannabinoids with similar structures in order to identify active cannabinoids that have the potential to treat specific diseases. Per InMed’s website, this type of bioinformatics assessment represents “significant promise for future drug discovery, as it integrates many data sets and builds holistic models to approach a specific disease.”

After discovering these promising active cannabinoids, InMed moves to test and confirm their activity in biological systems through in vitro and in vivo experimentation. It is at this stage of development that the company’s proprietary biosynthesis process of cannabinoid manufacturing will be most promising. InMed is currently developing a robust, high-yield biosynthesis process for manufacturing all 90+ naturally-occurring cannabinoids. By modifying the agriculture-based formula for harvesting cannabinoids, InMed aims to combine the inherent safety and known efficacy of the natural drug structure with the convenience, control and quality of 21st Century laboratory-based manufacturing processes.

The company’s pipeline currently includes two drug candidates in preclinical development, including INM-750 for the treatment of epidermolysis bullosa (EB) and INM-085 for the treatment of glaucoma. Referred to by the Dystrophic Epidermolysis Bullosa Research Association of America as “The Worst Disease You’ve Never Heard Of,” EB is a rare genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States. The condition currently has no approved treatment or cure. Through the development of INM-750, InMed is attempting to address this significant unmet medical need. The drug candidate replaces missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB.

INM-085, InMed’s second development candidate, is formulated to reduce the elevated intra-ocular pressure that is often associated with glaucoma. Additionally, the cannabinoids utilized in INM-085 are expected to provide neuroprotection for the retinal ganglion cells and other optic nerve tissues following topical administration. Although it is still in preclinical development, INM-085 targets a sizable market. According to the Glaucoma Research Foundation, glaucoma is a leading cause of blindness with no approved cure. The National Institutes of Health estimates that more than 3 million Americans currently have glaucoma, and more than 120,000 have been blinded by the disease.

InMed is focused on progressing toward validation of its drug candidate selection, using data to secure its patents and developing key disruptive technologies. In 2016, the company was successful in completing financings of $1.9 million. In January 2017, InMed completed a non-brokered private placement of common shares generating aggregate gross proceeds of C$1.5 million, strongly positioning the company to attract the new investment required to fund its aggressive growth strategies in 2017.

The company’s management team has well over a century of combined experience in the biopharmaceutical space. Company CEO Eric Adams has more than 25 years of experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance. During his time as CEO of enGene Inc., he led the gene therapy startup to a position at the head of the industry.

Joining Adams on the InMed management team are Chief Scientific Officer Dr. Sazzan Hossain; Senior Vice President, Clinical and Regulatory Affairs Alexandra D.J. Mancini; SVP, Corporate Strategy & Investor Relations Chris Bogart; and Chief Financial Officer Jeff Charpentier, as well as Chief Medical Officer Dr. Ado Muhammed, MD, DPM, MFPM.

Muhammed, in particular, has an extensive history in the pharmaceutical industry, having previously served as an executive of GW Pharmaceuticals, a global leader in the development of cannabinoid-based medicines. During his time as Associate Medical Director of that company, Muhammed played an instrumental role in the development and FDA approval of one of the first cannabis drugs. This GW Pharmaceuticals development program coincided with a sharp rise in share price from less than $9 in 2013 to more than $129 today, with the company’s current market value totaling more than $2.9 billion. Disclaimer

InMed Pharmaceuticals, Inc. Company Blog

InMed Pharmaceuticals, Inc. News:

InMed Announces Publication in European Journal of Pain

InMed Pharma Advances Cannabinoid EB Therapy -- CFN Media

InMed Signs R&D Agreement with ATERA

Converde Energy USA, Inc. (XFUL)

The QualityStocks Daily Newsletter would like to spotlight Converde Energy USA, Inc. (XFUL). Today, Converde Energy USA, Inc. closed trading at $0.0047, off by 4.08%, on 474,600 volume with 16 trades. The stock’s average daily volume over the past 60 days is 480,407, and its 52-week low/high is $0.0002/$0.10.

Converde Energy USA, Inc. (XFUL), d/b/a American Energy Partners Inc., and its group of companies are dedicated to delivering solutions wherever energy production and water meet technology. The company has positioned itself to benefit from above-favorable margins on each of its subsidiaries due to the synergy of the chain of revenues.

Hydration Company of PA (HCPA)
Hydration Company of PA focuses on sourcing, implementing and distributing reclaimed water at a profit. This subsidiary's competitive advantage mainly lies within its pure volume of reclaimed water and its access to low cost treatment with high flow rates and highly concentrated solids through the technologies of XFUL's partners. Because of the volume as well as the flexibility of the model established via patent pending methodology and conveyance methods, HCPA can effectively gain market share immediately as large corporations prefer access to one source that can supply massive amounts of reclaimed water regardless of drought conditions.

American Energy Solutions, LLC
American Energy Solutions, LLC utilizes a network of partners to provide off-the-shelf and custom-designed treatment technologies that contribute to HCPA's business model of low-cost treatment and distribution. As a provider of design, this subsidiary is capable of repeatable and synergistic services across the value chain. American Energy's long-term plan is to utilize an in-house team to grow market share as water use continues to become more critical to modern industry.

Gilbert Oil & Gas Company
Gilbert Oil & Gas Company is leveraging broad industry valuation experience to move forward on its mission to add shareholder value through drilling, operating, and partnership opportunities in the upstream oil and gas space. Equipped with the in-house capabilities necessary to source and evaluate opportunities for profitability, Gilbert is positioned to become a strong customer of XFUL's other subsidiaries, providing them with the foundation to attract other customers and enter new markets.

Integrated Business Strategy
By combining ownership of water sources via Hydration Company of PA, design and treatment solutions via American Energy Solutions, and a stream of promising opportunities via Gilbert Oil & Gas Company, XFUL is essentially creating a positive revenue feedback loop. This synergistic business model also opens opportunity for higher profit margins, additional revenue, and faster growth in new markets. Disclaimer

Converde Energy USA, Inc. Company Blog

Converde Energy USA, Inc. News:

NetworkNewsBreaks – American Energy Partners, Inc. (XFUL) Featured in Exclusive Audio Interview by NetworkNewsWire

Converde Energy USA, Inc. Appoints Josh Hickman, President of Subsidiary's O&G Operations and to Board of Directors

American Energy Partners, Inc. (XFUL) d/b/a Converde Energy USA, Inc. Engages NetworkNewsWire for Corporate Communications Solutions

Patriot One Technologies, Inc. (PTOTF)

The QualityStocks Daily Newsletter would like to spotlight Patriot One Technologies, Inc. (PTOTF). Today, Patriot One Technologies, Inc. closed trading at $0.59, off by 4.84%, on 62,315 volume with 29 trades. The stock’s average daily volume over the past 60 days is 71,640, and its 52-week low/high is $0.4665/$1.49.

Patriot One Technologies, Inc. (PTOTF) is leveraging seven years of development to create powerful technologies that mitigate security risks by detecting concealed weapons via novel radar technology.

Developed through a NATO-funded project at McMaster University, Patriot One's disruptive NForce CMR1000 technology is the first cost-effective solution available for active shooter prevention, the need for which is evidenced by an increasing number of active shooter events in the United States and worldwide.

A recent study that surveyed data going back as far as 1966 demonstrates that there have been significantly more mass shootings in the U.S. than any other country for decades. Statistics for the 46-year period shows that even though America only holds 5% of the world's population, it took count of 31% of all public mass shootings. According to the FBI, there were an astounding 160 incidents from 2000 to 2013 that resulted in 486 people killed and 557 wounded. In years 2014 and 2015, there were nearly six times as many incidents compared to 2000 and 2001. The disturbing trend shows that there will be increasingly more incidents if better preventative measures aren't taken.

Patriot One's patent-pending solution to this alarming progression enables stand-off detection, even on moving targets, with a "cognitive" ability to learn and identify new threats once deployed. The product is not intended to threaten the constitutional rights of legal gun carriers, and it is also void of privacy and health concerns of traditional detection technologies, which require subject compliance, present false positives, and are often slow, inefficient and costly.

In contrast, Patriot One's technology is small in size and can be "covertly" placed in a doorway or hallway to prevent planned attacks in public places like schools, concerts, stadiums, banks, airports, offices, hospitals, shopping centers and other facilities for which there are concerns. With this method of deployment, there is no subject compliance requirement. In addition, because an image of the target is not generated, there are also no privacy concerns. Detection is real-time and entirely computer-based, which means there is no need for human operators to alert security. This eliminates the safety concerns of a would-be operator, reduces the expense of a human operator, and enables overall accuracy of 93%.

The technology is designed to identify if someone is carrying a gun, knife, suicide vest, etc., by analyzing metal content and relating it to a database of known weapon signatures. Patriot One believes the widespread use of this detection technology could act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the nation and around the world.

The company is guided by a team of experts in the areas of high-frequency electromagnetics, counter-terrorism, conflict resolution, government/corporate interface, sensor development, proactive security and business development. Senior Management has partnered with, among other affiliates, Ridge Global, which was founded by recently appointed advisory board member Tom Ridge, the first head of the Department of Homeland Security, first U.S. Secretary of Homeland Security, and 43rd governor of Pennsylvania.

Along with its partners, Patriot One is addressing global concerns of active shooting events and other violent terrorist attacks. The key is to short-circuit the event through effective prevention technologies and security protocols. Disclaimer

Patriot One Technologies, Inc. Company Blog

Patriot One Technologies, Inc. News:

NetworkNewsWire Releases Exclusive Audio Interview with Patriot One Technologies, Inc. (PTOTF)

Patriot One Initiates Pacific Rim Sales with Aotea Security of New Zealand

Patriot One Marks 3-Months of Global PATSCAN Sales with $2.7M in Signed Agreements

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

StockMarketWatch
(TDW) +2,588.17%

2.

Penny Stock Titans
(PFGB) +1,200.00%

3.

QualityStocks
(IDDR) +56.25%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251